Debate over 'Right-to-Try' Laws
NORBERTO DUARTE/AFP/Getty Images
Lawmakers in three states have passed so-called "Right-to-Try" laws, which give terminally ill patients access to experimental drugs without FDA approval. Diane and guests discuss the growing demand for these laws and whether they jeopardize patient safety.
senior correspondent, Kaiser Health News; author of "Health Care Policy and Politics A-Z."
director of the division of medical ethics, New York University Langone Medical Center.
vice president, scientific and regulatory affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
communications director, The Goldwater Institute
commissioner of the Food and Drug Administration.